US 8101158
Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity
granted A61KA61K31/5377A61K9/0019
Quick answer
US patent 8101158 (Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity) held by The Regents of the University of California expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/5377, A61K9/0019